Quick Heal Technologies (QUICKHEAL) investor relations material

Executive summary

• Achieved INR 71.5 Cr net revenue in Q3 FY26, up 1.3% YoY, with diluted EPS of 1.2 and PAT of INR 6.6 Cr, a 5909.1% YoY increase.

• 9M FY26 net revenue at INR 212.3 Cr, down 1.0% YoY, with diluted EPS of 1.6 and PAT of INR 9.0 Cr, up 8.7% YoY.

• Enterprise revenue grew 37.1% YoY in Q3 and 20.4% YoY for 9M FY26, while consumer revenue declined 21.2% YoY in Q3 and 12.1% YoY for 9M.

• New senior management appointments and promotions were made to strengthen leadership in engineering, delivery, people & culture, and cyber awareness.

• Secured a major INR 64 Cr government order with a 5-year fulfillment period; order book exceeds INR 80 Cr.

Financial highlights

• Q3 FY26 gross margin at 95.9%, with EBITDA of INR 0.5 Cr (0.6% margin) and PAT margin of 9.2%.

• 9M FY26 gross margin at 97.0%, EBITDA at INR -0.1 Cr (0.0% margin), and PAT margin of 4.2%.

• Q3 FY26 operating costs decreased across R&D, sales & marketing, and general administration compared to previous quarters.

• Other income in Q3 FY26 rose to INR 9.0 Cr.

• Paid-up equity share capital as of Dec 31, 2025: ₹54.21 Cr; market cap: ₹1,442.4 Cr; share price: ₹266.05.

Outlook and guidance

• Focus on expanding enterprise segment with niche solutions for large enterprises and strategic geographic expansion.

• Continued investment in product innovation, cloud-native applications, and AI-driven cybersecurity.

• Serviceable Operatable Market projected to grow from INR 3,000 Cr in FY25 to INR 4,000 Cr by FY27, driven by new products and DPDP enforcement.

• Company expects sustained growth in FY26 and beyond, leveraging new product launches and leadership hires.